FGFR3-TACC3 [K650N] /BaF3
CBP73377
詢(xún) 價(jià)
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. Introduction | |
| Cell Line Name： | FGFR3-TACC3 [K650N] /BaF3 |
| Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Application: | Anti-proliferation assay and PD assay |
| Freeze Medium: | 90% FBS+10% DMSO |
| Complete Culture Medium: | RPMI-1640+10%FBS |
| Mycoplasma Status: | Negative |
| II. Background | |
|
FGFR3-TACC3 results from the fusion of FGFR3 and TACC3, demonstrating constitutive kinase activity, transforming activity in culture and ability to drive tumor growth in xenografts (PMID: 25294908, PMID: 22837387). FGFR3-TACC3 has been identified in lung adenocarcinoma and glioblastoma (PMID: 25294908, PMID: 22837387). |
|
| III. Representative Data | |
|
1.WB of FGFR3-TACC3 [K650N] /BaF3
|
|
|
2. Sanger of FGFR3-TACC3 [K650N] /BaF3
Figure 2. FGFR3-TACC3 [K650N] /BaF3 K650N
Figure 3. FGFR3-TACC3 [K650N] /BaF3 FGFR3-TACC3 |
|
|
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 FGFR3-TACC3 K650N Cells (C3). |
|
